Biotage Achieves ISO 14001:2004 Certification
News Jun 14, 2016
Biotage is pleased to announce that they have achieved ISO 14001:2004 certification. This comes after years of dedicated work and close collaboration between employees, consultants and managerial staff.
In addition to establishing a series of quality standards regarding business practices and the environment, ISO 14001:2004 certification also comes with various other benefits to the titleholder, including: reduction of costs through efficient use of materials and management of legal compliance by prioritizing environmental risks.
“We at Biotage are incredibly honored to receive ISO 14001 certification of our environmental management systems that have been developed over the years. This certification is much more than just legal compliance; for us, it is a driver by which Biotage can effectively manage responsible business practices that seek to limit negative environmental impact through control of emissions and other potentially harmful actions” said Chris Williams, UK Managing Director, Biotage.
ISO 14001:2004 helps businesses like Biotage manage challenges, systems and risks concerning environmental performance. The certification serves as assurance to management, employees and external partners that the environmental impact of operations is being measured, monitored and continually improved.
Biotage’s official certification of its environmental management system was confirmed on 5th May 2016 by BSI, the reputable certification body that provides compliance, risk, and technical support.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Simple Sugar Prevents Neurodegeneration in Lysosomal Storage DiseaseNews
New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)READ MORE